The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitonealdocetaxel (XP ID) in patients with advanced gastric cancer with peritoneal metastasis.
 
Hyungwoo Cho
No Relationships to Disclose
 
Min-Hee Ryu
No Relationships to Disclose
 
Changhoon Yoo
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Sook Ryun Park
No Relationships to Disclose
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Beom Su Kim
No Relationships to Disclose
 
Moon-Won Yoo
No Relationships to Disclose
 
Jeong Hwan Yook
No Relationships to Disclose
 
Byung Sik Kim
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech